Project Grant S10OD036216

Award Date 6/15/25
Completion Date 6/14/26
Dollars Obligated $689K
Funding Federal Agency
Office of the Director
Federal Grant Program
93.351
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
The National Institutes of Health (NIH) awarded a $656,148 Project Grant under the Research Infrastructure Programs (CFDA 93.351) to Trustees of Boston University, doing business as the Boston University Medical Campus. The grant will fund the acquisition of a BD FACSDiscover S8 spectral cell sorter with advanced imaging capabilities to replace the university's aging cell sorting equipment. This cutting-edge instrument will enable high-quality cell sorting and comprehensive phenotypic analyses...
This federal Project Grant award from the National Institutes of Health (CFDA 93.351 - Research Infrastructure Programs) provides $799,322 to Northwestern University to purchase a state-of-the-art BD FACSDiscover S8 cell sorter with CellView image technology. This high-dimensional flow cytometry system will enable Northwestern's Flow Cytometry Core Facility to accommodate growing demand for advanced, high-parameter cell sorting capabilities. The new instrument will enhance the facility's ability...
This federal Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) provides $490,899 to The Johns Hopkins University for the acquisition of a BD FACSAria Fusion cell sorter. This advanced 4-laser, 16-fluorescent detector flow cytometry instrument will significantly enhance the research capabilities of 22 user groups within the Johns Hopkins School of Medicine who rely on cell sorting for a diverse range of NIH-funded projects....
This federal Project Grant award from the National Institutes of Health (NIH) under the Research Infrastructure Programs (CFDA 93.351) provides $631,365 to Pennsylvania State University, doing business as Penn State Milton S. Hershey Medical Center, to purchase a BD FACSDiscover S8 cell sorter for the university's flow cytometry core facility. The new high-parameter flow cytometer will enable the isolation and purification of target cell populations from complex biological samples, supporting...
This federal Project Grant award of $634,038 from the National Institutes of Health (CFDA 93.351 - Research Infrastructure Programs) will provide the University of California, Davis with a BD FACSymphony S6 flow cytometric sorter. This instrument will be integrated into the university's established Flow Cytometry Core facility to support over 20 current NIH-funded research projects spanning basic, translational, and clinical research areas, including studies on therapeutic HIV vaccines, SIV...
The Regents of the University of California, San Francisco (UCSF) has been awarded a $752,359 Project Grant under the National Institutes of Health's Research Infrastructure Programs (CFDA #93.351) to purchase a state-of-the-art Thermo Fisher Scientific Invitrogen Bigfoot Full Spectrum Cell Sorter. This high-throughput, full-spectrum flow cytometer will complement UCSF's existing suite of advanced cell analysis instruments, enabling researchers to simultaneously analyze up to 35-40 parameters on...
This $350,000 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) will fund the acquisition of a BD FACSymphony S6 flow cytometer for the University of Toledo Flow Cytometry Core. The new instrument will replace the university's 16-year-old flow cytometer, providing enhanced capabilities for NIH-funded research projects in molecular biology, pathology, virology, immunology, and cell biology across the...
This federal Project Grant award from the National Institutes of Health (NIH) Research Infrastructure Programs (CFDA 93.351) provides $472,723 to Drexel University to acquire a BD Biosciences Symphony A5 spectrally enabled flow cytometer with 5 lasers, 48 fluorescence and 2 scatter channels, and a high-throughput sampler system. This state-of-the-art flow cytometer will become the flagship instrument for Drexel's newly created Flow Cytometry Core Facility, supporting deep profiling of cellular...
The National Institute of General Medical Sciences (NIGMS) awarded a $243,119 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Puerto Rico Medical Sciences Campus (UPR-MSC). This award will enable the purchase of a state-of-the-art BD FACSymphony A1 flow cytometer with 4 lasers to support health-related research projects and educational needs at UPR-MSC. The flow cytometer will allow for the advanced analysis of immune cells and other...
This federal Project Grant award from the National Institutes of Health (NIH) Research Infrastructure Programs (CFDA 93.351) provides $454,942 to the University of California, San Diego (UCSD) to purchase a Cytek Aurora full-spectrum flow cytometer. The instrument will be housed in UCSD's Human Embryonic Stem Cell Core Facility (HESCCF) and made available to researchers across five member institutions of the Sanford Consortium for Regenerative Medicine. The new high-end flow cytometer will...

This $689,031 Project Grant from the National Institutes of Health's Research Infrastructure Programs (CFDA 93.351) will enable The Feinstein Institutes for Medical Research, the research arm of Northwell Health, to acquire a BD FACSymphony S6 SE spectral cell sorting platform. This high-parameter flow cytometry analyzer will allow researchers to isolate rare cell populations and conduct advanced cellular analyses across 8 NIH-funded projects in autoimmune disease, cancer, and hematological disorders. The new cell sorter offers enhanced capabilities over the organization's current instruments, including the ability to simultaneously sort 6 distinct cell populations using up to 50 different parameters. This instrumentation will improve the efficiency and precision of the Feinstein Institutes' clinical and translational research programs, supporting the development of novel treatments with fewer side effects.

Generated 7/1/25, 3:59 AM